Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Budding uninhibited by benzimidazoles 1 might be a poor prognosis biomarker promoting the progression of papillary thyroid cancer.

Environmental toxicology - 1 Sept 2023

Jiang Wenjie, Yu Yan, Bhandari Adheesh, Hirachan Suzita, Dong Xubin, Huang Xiaoli, Qu Jinmiao, Chen Chengze

Abstract excerpt

BACKGROUND: Papillary thyroid carcinoma (PTC) is one of the most widespread malignant tumors of the endocrine system, with a high incidence. Budding uninhibited by benzimidazoles 1 (BUB1), one of the spindle assembly checkpoint (SAC) genes, is a multitask protein kinase required for eukaryotic chromosome segregation. Although BUB1 has been explored in several types of cancer, its biological role and molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Carcinoma, Papillary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 37163344
DOI: 10.1002/tox.23812

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Budding uninhibited by benzimidazoles 1 might be a poor prognosis biomarker promoting the progression of papillary thyroid cancer.PMID 37163344Read ↗

Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma.Semantic proximity Read ↗

Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype in lung adenocarcinomaSemantic proximity Read ↗

Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid.Semantic proximity Read ↗

Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapiesSemantic proximity Read ↗

BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast CancerSemantic proximity Read ↗

Overexpression of BubR1 Mitotic Checkpoint Protein Predicts Short Survival and Influences the Progression of CholangiocarcinomaSemantic proximity Read ↗

Clinical value and potential mechanisms of BUB1B up-regulation in nasopharyngeal carcinomaSemantic proximity Read ↗

UBE2T promotes PTC progression by activating the JAK/STAT3 pathway via negative regulation of SOCS2Semantic proximity Read ↗

TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcomaSemantic proximity Read ↗

Survival of drug-resistant metastatic papillary thyroid cancer under drug treated conditions via upregulation of sarco/endoplasmic reticulum calcium ATPase 1Semantic proximity Read ↗

CDC23 regulates cancer cell phenotype and is overexpressed in papillary thyroid cancerSemantic proximity Read ↗

BUB1B MITOTIC KINASE DRIVES THERAPY RESISTANT PROSTATE CANCERSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.